North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa make up the dilated cardiomyopathy market. Due to an increase in congestive heart failure cases, the DCM market in North America has seen tremendous expansion. According to the European Heart Network's 2017 estimate, there are around 3.9 million deaths caused by cardiovascular disease in Europe, with over 1.8 million deaths in the European Union. The Asia Pacific market is the third largest and is predicted to develop at a faster rate as a result of growing awareness of cardiovascular disease and need for generic medications, which will help the DCM market grow.
Read More:
https://bloggerstrive.blogspot.com/2022/03/rise-in-congestive-heart-failure-fuels.html
Click here for Dilated Cardiomyopathy Market Report:
https://www.coherentmarketinsights.com/market-insight/dilated-cardiomyopathy-market-514
